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Abstract: Chronic stress is encountered in our everyday life and is thought to contribute to a number
of diseases. Many of these stress-related disorders display a sex bias. Because glucocorticoid
hormones are the main biological mediator of chronic stress, researchers have been interested in
understanding the sexual dimorphism in glucocorticoid stress response to better explain the sex
bias in stress-related diseases. Although not yet demonstrated for glucocorticoid regulation, sex
chromosomes do influence sex-specific biology as soon as conception. Then a transient rise in
testosterone start to shape the male brain during the prenatal period differently to the female brain.
These organizational effects are completed just before puberty. The cerebral regions implicated in
glucocorticoid regulation at rest and after stress are thereby impacted in a sex-specific manner. After
puberty, the high levels of all gonadal hormones will interact with glucocorticoid hormones in specific
crosstalk through their respective nuclear receptors. In addition, stress occurring early in life, in
particular during the prenatal period and in adolescence will prime in the long-term glucocorticoid
stress response through epigenetic mechanisms, again in a sex-specific manner. Altogether, various
molecular mechanisms explain sex-specific glucocorticoid stress responses that do not exclude
important gender effects in humans.
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1. Introduction
Glucocorticoid hormones (GC), end products of the hypothalamic-pituitary-adrenal
axis (HPA) are steroids produced by the adrenal glands that regulate many functions in
the body including inflammation, energetic metabolism, growth, as well as mood and
memory. GCs are also highly responsive to stress with both rapid and enduring effects
on the body. The molecular mechanisms responsible for these effects have been largely
investigated in animal models. Sexual dimorphism in baseline and stress-induced GC
action are well described and could explain the sex differences observed in the prevalence
of stress-related diseases. In this selective review we first briefly review the stress response
system, then we present data supporting a role for sex chromosomes into sex differences
followed by evidence of gonadal influences across development in shaping the sex-specific
GC sensitivity. Finally we give examples of long-lasting effects of early-life stress on GC
stress response according to sex. Although these various genetic, developmental, and
programming effects are presented separately they obviously synergize within individuals
either to exacerbate or to reduce sexual dimorphism.
2. Stress Response System, the Hypothalamic-Pituitary-Adrenal Axis, and GC Hormones
A loss of control, a threat, an uncertain or unpredictable situation, trigger a stress
response. This arousal activates the amygdala (a group of neuronal nuclei located in the
temporal median lobe of the brain) and leads to the release of the neuropeptide corti-
cotropin releasing factor (CRF) from the paraventricular nucleus of the hypothalamus. CRF
together with arginine vasopressin (AVP) is transported through the hypophyseal portal
capillary system from the hypothalamus to the pituitary where they stimulate the blood
release of adrenocorticotropin hormone (ACTH), which in turn activates in the adrenal
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glands the synthesis of GC hormones (cortisol in human and corticosterone in rodents) and
their secretion in the bloodstream [1,2] (Figure 1). In blood, most GCs circulate bound to
corticosteroid binding globulin (CBG) with high affinity and to albumin with low affinity.
Only free GCs will bind to their receptors in target cells such that a pool of CBG-bound
GCs circulate in an inactive form and is released upon cleavage of the CBG-GC complex
making CBG a reservoir and delivery molecule [3]. GCs have two types of receptors,
the mineralocorticoid receptor (MR) presenting a high affinity for GCs but an expression
restricted to some tissues and the GC receptor (GR) having a ten-time lower affinity but
a much wider distribution in the body. Both GR and MR are nuclear receptors located in
the cytosol when unbound and translocated to the nucleus upon binding to GCs where
dimers of the hormone-receptor complex will activate the expression of downstream genes
by binding to GC response elements (GRE) present in the DNA sequence or by repressing
other genes by preventing other nuclear factors, such as nuclear factor kappa B (NFKB)
or activation protein 1 (AP-1), to activate their target genes through protein–protein in-
teraction [4,5]. Membrane MR and GR have also been reported permitting fast actions
of GC within the brain [6,7]. GC hormones regulate their own synthesis by a negative
feedback control on CRF transcription in hypothalamus or ACTH expression in pituitary.
The molecular mechanisms for CRF gene inhibition by GR are still debated. Some stud-
ies reported GR binding to a negative GRE in the promoter region of the CRF gene [8]
while others found that inhibition of CRH by GR involves protein–protein interaction
with CREB (C-AMP Response Element-binding protein), preventing CREB binding to the
CREB response element present in CRF promoter [9]. As for ACTH down-regulation in the
pituitary, it was shown that GR binds to a GRE within the pro-opiomelanocortin (POMC)
gene (precursor of ACTH peptide) but also GR interacts with nuclear receptor subfamily
4 group A member 1(NR4A1) transcription factor to prevent POMC induction [10]. Fur-
thermore, limbic structures such as the hippocampus and the prefrontal cortex do contain
GRs and are exerting a tonic inhibition on the hypothalamic-pituitary-adrenal axis that is
relieved during stress [11]. Intra-adrenal GR-mediated negative feedback has also been
described, involving stimulation of the steroidogenic co-repressor Nuclear Receptor Sub-
family 0 Group B Member 1 (NR0B1) and prevention of NR4A1 binding on the promoter of
Star gene [12]. Finally, GCs can be synthesized locally by the enzyme 11b-hydroxysteroid
dehydrogenase type 1 which regenerate GCs from their inactive metabolite. This enzyme
is present in liver, adipose tissue, and brain and can represent up to 40% of circulating GCs.
Conversely, 11 β-hydroxysteroid dehydrogenase type 2 is an enzyme metabolizing GCs
which is present in aldosterone target tissues like kidney to prevent GC binding to MR [13].
GCs are irreversibly metabolized in the liver thanks to the enzymes 5α and 5β reductase.




Figure 1. Representation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to the secre-
tion of glucocorticoid hormones (cortisol in humans, corticosterone in rodents). Prefrontal cortex 
and hippocampus regulating negatively the HPA axis have a red arrow whereas amygdala that 
regulates the HPA axis positively has a green arrow pointing to the hypothalamus. Glucocorti-
coids regulate their own synthesis by feedback controls (thin blue arrow). 
3. Genetic Causes of Sexual Dimorphism 
As soon as conception, male and female mammals differ by the presence of sexual 
chromosomes in their cells, XX in females and XY in males. The two pseudo-autosomal 
regions (PAR1 and PAR2) located at the tips of chromosomes X and Y share the same 
genes which are thus inherited as autosomal genes and allow the X and Y chromosomes 
to pair and properly segregate during meiosis in males [14]. There are about 55 genes on 
Y chromosome and 29 found in the PARs, so the rest of them (~25 genes) are expressed 
only in males. One of the X chromosome of females is inactivated by epigenetic mecha-
nisms to avoid double dose of X-linked genes compared to males [15]. This is true for most 
genes but some genes escape to the X inactivation specifically during development. Fur-
thermore, the inactivation of maternal versus paternal X chromosome is random in fe-
males, which also impact gene expression when genes are under genomic imprinting spe-
cific to the maternal or paternal allele [16]. The X chromosome in male is necessarily from 
maternal origin, so more heterogeneity of expression could be observed for some X chro-
mosome-linked traits in females. Interestingly, X-linked genes are more highly expressed 
in the brain versus other tissues [17] so those that escape X-inactivation are good candi-
dates for sexual differences in brain development that may impact the HPA axis regula-
tion. A possible example is given by the Frm1 gene for which inactivation is responsible 
of fragile X syndrome. Affected males have more severe symptoms of mental retardation 
but also of social anxiety and they display higher cortisol levels [18]. A direct effect of 
Frm1 gene on cortisol levels sex differences is not yet elucidated but may rise from the 
involvement of Frm1 in dendritic spines formation and maintenance in brain regions con-
trolling the HPA axis regulation. 
Another way sex dimorphism may appear from, is when parents differentially influ-
ence gene expression in the brain of daughters versus sons. A genome-wide study identi-
fied preferential selection of the maternally inherited X chromosome in glutamatergic 
neurons of the female prefrontal cortex. Such sex-specific genomic imprinting inheritance 
is not restricted to X-linked genes as 347 autosomal genes with sex-specific imprinting 
features were also identified in adult brain of offspring, including prefrontal cortex, hip-
pocampus and hypothalamus [19]. These data are particularly interesting given that these 
cerebral regions strongly regulate the HPA axis and the release of GCs under stress. 
Figure 1. Representation of the hypothalamic-pituitary-adrenal (HPA) axis, leading to the secretion
of glucocorticoid hormones (cortisol in humans, corticosterone in rodents). Prefrontal cortex and
hippocampus regulating negatively the HPA axis have a red arrow whereas amygdala that regulates
the HPA axis positively has a green arrow pointing to the hypothalamus. Glucocorticoids regulate
their own synthesis by feedback controls (thin blue arrow).
3. Genetic Causes of Sexual Dimorphism
As soon as conception, male and female mammals differ by the presence of sexual
chromosomes in their cells, XX in females and XY in males. The two pseudo-autosomal
regions (PAR1 and PAR2) located at the tips of chromosomes X and Y share the same
genes which are thus inherited as autosomal genes and allow the X and Y chromosomes to
pair and properly segregate during meiosis in males [14]. There are about 55 genes on Y
chro oso e and 29 found in the PARs, so the rest of them (~25 genes) are expressed only
in males. One of the X chromosome of females is inactivated by epigenetic mechanisms to
avoid double dose of X-linked genes compared to males [15]. This is true for most genes but
some genes escape to the X inactivation specifically during development. Furthermore, the
inactivation of maternal versus paternal X chromosome is rand m in females, which also
impact gene expression wh n genes are under omic imprinting spe ific to the maternal
or paternal allele [16]. The X chromosome in male is necessarily from mat rnal origin, so
more heterogeneity of expressio could be observed for some X chromosome-linked traits
in females. Interestingly, X-linked genes are more highly xpress d in the brain versu other
issues [17] so those that escape X-inactivation are good candida es for sexual differe ces in
brain development that may impact th HPA axis regul tion. A possible example is given
by the Frm1 g ne for which i activation is responsible of fragile X sy drome. Affected
m les have more sever symptoms of mental retardation but also of social anxiety and
hey display higher cortisol levels [18]. A d rect effect f Frm1 gene on cortisol levels sex
differences is not yet elucidate but may r e from he involvement of Frm1 in dendritic
spin s formation and maintenance in brain regions controlli g the HPA axis regulation.
Another way s x dim rphism may appear from, is when parents differentially in-
flue ce gene expression in the brain of daughters versus sons. A genome-wide st dy
identified preferential selection of the maternally inherited X chro osome in glutamatergic
neurons of the female prefrontal cortex. Such sex-specific genomic imprinting inheritance
is not restricted to X-linked genes as 347 autosomal genes with sex-specific imprinting
features were also identified in adult brain of offspring, including prefrontal cortex, hip-
pocampus and hypothalamus [19]. These data are particularly interesting given that these
cerebral regions strongly regulate the HPA axis and the release of GCs under stress.
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4. Sex Dimorphism Related to Gonadal Hormones across Development
4.1. Neonatal Period
Around birth the expression of the Y-linked Sry gene triggers testes differentiation
with the production of testosterone in male rodents as a prenatal surge in late gestation
and a second surge that occurs immediately after birth [20]. In humans this testosterone
surge is present postnatally only [20,21]. Circulating neonatal testosterone has profound
effects on organ development such as liver and brain that in turn will sculpt HPA activity
and reactivity after puberty and result in sex dimorphism.
The first 2 postnatal weeks in rodents have been termed the “stress hypo-responsive
period” because of very low basal and stress-induced corticosterone levels. In human
this period may correspond to childhood [22]. This low activity of the HPA axis is due in
large part to the limited expression of SerpinA6 gene in liver, leading to the production
and secretion of CBG in plasma. Indeed, CBG levels set the level of basal circulating
GCs in great part because it increases GCs half-life in plasma by preventing their plasma
clearance as observed in CBG knock-out mice [23]. Also, by sequestering GCs in inactive
forms, CBG stimulates adrenal gland growth and function in order to maintain free CORT
levels [24]. This low activity of the HPA axis after birth is also reflected in the low expression
of 11β-hydroxysteroid dehydrogenase type 1 (Hsd11b1), that regenerate GCs from their
inactive metabolite and 5α-reductase type I (Srd5a1) which irreversibly inactivate GCs
before clearance [24].
Neonatal testosterone surge will influence HPA axis sex dimorphism by indirectly
modulating these 3 hepatic genes SerpinA6, Hsd11b1, and Srd5a1, through the growth
hormone-insulin growth factor I (GH-IGF-1) pathway that regulate these genes. Indeed,
in rodents, testosterone exposure during the first days of life determines the sex-specific
pattern of GH secretion in adulthood which show more frequent and higher amplitude
secretory pulses in males compared to females [25]. This GH secretory pattern is regulated
in hypothalamic neurons by somatostatin and growth hormone-releasing hormone that
inhibits and stimulates GH release from the anterior pituitary respectively. Testosterone
crosses the blood-brain barrier to reach the brain where it is converted to estradiol by the
enzyme aromatase. Prevention of testosterone surge by gonadectomy at birth feminizes
GH secretory pattern in males while neonatal exposure to testosterone or exposure to
exogenous estradiol in females masculinizes GH release. Interestingly, continuous infusion
of GH (female pattern) increases plasma CBG in hypophysectomized males and females
while intermittent GH exposure (male pattern) has no effect or suppresses CBG levels in
females [26]. Thus, sex differences in CBG levels that emerge around puberty are due
in large part to sex-specific GH secretory pattern that is determined by neonatal testos-
terone. Similarly, GH regulates differentially Hsd11b1 and Srd5a1 in male and female liver,
accentuating sexual dimorphism in GC levels appearing after puberty (reviewed in [24]).
In both humans and rodents, several brain regions involved in stress and CRF-
mediated HPA axis regulation, such as the prefrontal cortex, amygdala, hippocampus,
and hypothalamus undergo significant maturation in the perinatal period and during
childhood and adolescence. These areas also demonstrate significant sex differences in
both structure and function into adulthood. Besides sex chromosomes, gonadal hormones
do affect the rates of maturation of these brain regions between males and females, and
thereby ultimately determining the GC stress sensitivity during adulthood [27].
Neonatal testosterone, converted to estradiol, drives masculinization, an active process
of neurodevelopment including neurogenesis, cellular differentiation, axon guidance,
synaptic pruning, apoptosis, and phagocytosis [21]. Masculinization has been associated
with male-specific reproductive behavior but it also impacts HPA functioning. Indeed,
gonadectomy around birth in males increases basal and stress-induced corticosterone
levels in adults [28] while a single injection of testosterone in females on the day of birth
decreases the amplitude and frequency of corticosterone pulsatile secretion as well as stress-
induced levels [29]. Additionally, the inhibition of aromatase enzyme in male neonates
increases stress-induced corticosterone once rat are adults and also increased c-fos mRNA,
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a marker of neuronal activation, in the paraventricular nucleus of the hypothalamus and in
hippocampus [30]. Thus, neonatal testosterone, through its conversion to estrogen and via
estrogen receptor alpha (ERα) signaling has a suppressive effect on GC stress response in
adult rodents by organizational effect in liver and in brain.
Humans, like rodents are exposed to a gestational testosterone surge and testosterone
aromatization does occur but masculinization of the brain seems to be mediated by an-
drogen receptor (AR) signaling. Indeed, men with defective aromatase enzyme conserved
male-specific behavior while men with AR mutations, leading to complete androgen in-
sensitivity syndrome, exhibit female-typical behavior [31]. A direct effect of neonatal
testosterone on GH release has not been reported in men where GH secretion pattern are
less pronounced compared to the rat. Nevertheless, higher nocturnal pulses of GH in men
were reported whereas women had more continuous GH secretion and more frequent GH
pulses that are of more uniform size [32]. Further, GH-deficient adults with GH replace-
ment display a negative correlation between plasma IGF1 and CBG (decreased by 30%)
suggesting down-regulation of CBG by IGF-1, but no significant effect on total cortisol was
detected [33].
4.2. Puberty Period
A second critical period for the organizational influence of gonadal hormones on the
HPA axis is puberty. Puberty is marked by many changes in neuroendocrine processes,
one of which is the shift in stress reactivity exhibited by the HPA axis. Prepubertal rats
of both sexes show an extended hormonal stress response compared to adults (~40 min
longer) and do not habituate to repetitive stress [34]. Studies in male rats showed that
prepubertal gonadectomy results in an HPA axis that is less responsive to androgen
treatment in adulthood, i.e., lower inhibition by androgens of corticosterone secretion
and of frequency and amplitude of corticosteroid pulses. In contrast, animals that were
gonadectomized in adulthood showed a normal response to testosterone replacement [35].
Furthermore, stress-induced increase in CRF and AVP mRNAs in the hypothalamus are
suppressed by testosterone only in the animals that were castrated in adulthood. Thus,
testosterone exposure during the prepubertal period is important for the masculinization
of GC responses to stress in adulthood. Unlike testosterone, pubertal estradiol exposure is
not essential for sculpting female-typical HPA responses in adulthood since ovariectomy
before or after puberty will result in the same stimulatory effect of estradiol on basal and
stress-induced corticosterone [36].
4.3. Adulthood
After these two organizational periods, adulthood is characterized by activation of sex
differences owing to elevated concentrations of gonadal hormones. After puberty female
rodents display higher levels of circulating GCs at rest and after stress. Of note, free active
GCs are equivalent to males because of higher CBG levels [23]. In humans, inconsistent
data are reported in the literature about sex differences in cortisol levels, probably because
of the difficulty to measure cortisol in controlled conditions. For example, females were
found to have higher free cortisol levels than males, as in rodents, in one study with
1258 participants [37] but the opposite was found in another one where there was no
differences at rest and a higher response after a social stress in men [38]. A meta-analysis
for post-stress cortisol levels concluded that men had higher cortisol levels than women
but the sex differences could be explained by variations in methodologies [39]. Increased
basal levels of total GCs in females are largely mediated by CBG since in Cbg ko mice, GCs
are very low in both sexes and 24 h urine corticosterone levels become equivalent in males
and females [23]. Similarly, in human totally deficient in CBG, cortisol concentrations are
very low and do not differ between sexes [40]. Sex differences are found also centrally
with female rodents presenting higher levels of CRF and AVP mRNA in the hypothalamus
as well as increased POMC expression in pituitary compared to males [41]. Feedback
regulation of the HPA axis is less efficient in females and is associated with lower binding
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of GR in the hypothalamus as well as in the pituitary [42]. Furthermore, the analysis
of hypothalamus-specific ko of GR in mice showed that negative feedback is disrupted
in males but not in females suggesting that the site of feedback control is elsewhere in
females [43].
4.4. Molecular Aspects
Androgens down-regulate both basal and stress-induced GC levels through central
and peripheral actions while estrogens have a stimulating effect not only by increasing
CBG but also by impairing GC feedback or centrally inducing the HPA axis. This effect of
estrogens depends on the presence or absence of progesterone that indirectly counteracts
estrogen stimulating action [27,44].
Testosterone acts through AR or through ERα or ERβ after testosterone conversion to
estradiol or successive conversion of testosterone to dihydrotestosterone and 5α androstane
3β,17β diol (3β-diol). Estrogens bind to both ERα and ERβ. As GR and MR, AR, Erα,
and ERβ are members of the family of steroid nuclear receptors that are ligand-inducible
transcription factors; they have a centrally located DNA-binding domain (DBD) which
is connected via a hinge region to a carboxyterminal ligand-binding domain (LBD) and
an amino-terminal activation function (NTD). The DBD consists of two zinc-coordinating
modules and forms the signature domain of the nuclear-receptor family. Nuclear receptors
remain in an inactive form in the cytoplasm when unbound and then shuttle to the nucleus
upon hormone binding to activate downstream target genes on specific hormone response
element in the DNA sequence or to down-regulate genes by protein–protein interaction
with other transcription factors. Membrane ER receptors have also been described allowing
non-genomic rapid actions of estrogens through second messenger pathways and ion
channels [45].
Testosterone influence on HPA axis tone is blocked by intra-cerebro-ventricular in-
fusion of a 5α-reductase inhibitor, which converts testosterone to the more potent and
non-aromatizable androgen, dihydrotestosterone (DHT), suggesting central effects of the
hormone. Anatomically, the action of testosterone on HPA drive is thought to occur via
the bed nucleus of the stria terminalis (BNST) in addition to the paraventricular nucleus
(PVN) of the hypothalamus since AR are particularly abundant in BNST neurons that
projects to the PVN. Androgen response elements are present in the CRF gene [46]. HPA
suppression by androgens is obtained by a decrease of CRF gene and an increase of its
receptor CRFR1 in hypothalamus [47]. This central effect explains increased POMC mRNA
as well as hypertrophic adrenal glands observed in AR knockout mice but decreased GR
in the pituitary was also detected and appeared to be regulated by androgen although no
classical androgen response element (ARE) was found in the GR gene [47]. Androgens can
also interact with ERβ via conversion of testosterone to estradiol or through 3β-diol, which
has a high affinity for ERβ, but very low affinity for AR. Erβ are abundant in the PVN and
specific activation of these receptors suppresses stress-induced ACTH and GC secretion
as well as c-Fos expression in the PVN [48]. Mechanistically, Erβ-3β-diol complex was
shown to bind to an estrogen response element (ERE) within the promoter of the AVP gene,
thereby inhibiting ACTH release from pituitary [49]. Additionally, Erβ-3β-diol complex
also binds to an ERE in the promoter of the oxytocin gene [50] including in humans [51]
to induce oxytocin production which is known to attenuate stress-induced ACTH and
GC secretion.
ERα are not present in the PVN so direct influence of gonadal hormone on CRF
neurons of the PVN are excluded. However, ERα are abundant in the peri-PVN where
they mediate the inhibiting influence of estradiol on the negative feedback of GC thereby
up-regulating HPA drive. Indeed, estradiol injection directly within the hypothalamus
prevents dexamethasone (a GR agonist) suppression of corticosterone release in rats via
ERα but not ERβ [1]. Additionally, the CRF gene contains ERE and ERα as well as ERβ
were shown to induced CRF in neuroblastoma cell lines [52]. However, ERα and ERβ
were found to regulate CRF-BP gene expression in opposite ways, ERα inducing and ERβ
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repressing CRF-BP [53]. Although CRF-BP is often reported to inhibit CRF by preventing
its binding to CRFR1 in the pituitary, transgenic mice with overexpression of CRF-BP
display elevated CRF levels and no change in ACTH and GC levels [54]. Thus the ERα
and ERβ regulation of CRF-BP fits with a positive effect of ERα and a suppressive one
of ERβ on CRH. The influence of testosterone or estradiol on adrenal steroidogenesis
was studied by transcriptomic analyses comparing rat controls to rats gonadectomized
or gonadectomized and replaced by either testosterone (males) or estradiol (females).
Although the effect of these hormonal manipulations resulted in the expected outcome for
corticosterone levels, unexpected upregulation of many genes was found after testosterone
replacement, including genes associated with lipids and cholesterol metabolism while
estradiol replacement inhibited the expression of numerous genes, mainly those involved
in tumor necrosis factor alpha (TNFα) signaling through NFKB [55]. Elevated CBG levels
in females are ensured by estrogen stimulation of SERPINA6 gene through ERα binding in
its promoter region [56–58], which explains very high cortisol and CBG levels in women
taking estradiol contraceptive pills or during pregnancy.
Finally, progesterone acts on the HPA through its metabolite 3α-5α tetrahydropro-
gesterone more commonly known as allopregnanolone. Allopregnanolone is a positive
allosteric modulator of Υ-aminobutyric acid receptors (GABAA) through which it inhibits
CRF neurons within the PVN, consequently decreasing CRF and GC release, in particu-
lar after an acute stress [59]. Allopregnanolone is induced by stress in both males and
females through adrenal steroidogenesis but the additional progesterone levels released
from ovaries are responsible for a part of the sex dimorphism in GC stress response.
5. Sex-Specific Programming Effects of Stress on the HPA Axis
Elevations in GCs that result from environmental stressors or exogenous GCs can
have programming effects on brain structure regulating the HPA axis when the exposure
occurs during sensitive periods. Two sensitive periods have been identified, perinatal time
and adolescence where intense brain development occurs.
5.1. Perinatal Environment
Maternal stress has been shown to alter the development and sensitivity of offspring
HPA stress axis in the long-term and in a sex-specific manner, with increased male vulnera-
bility in particular when the stress happens early in pregnancy. Fetal exposure to maternal
GCs is known to be regulated by the placental GC barrier ensured by various mechanisms
including 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) which metabolize GCs to
inactive forms (cortisol to cortisone in human, corticosterone to 11-dehydrocorticosterone
in rodents), and GR isoforms such as GRβ conferring GC resistance. The placenta expresses
the fetal genetic sex [60] which explains sex-specific effect of maternal stress. Considering
that the newborns are brought up by mothers, that are themselves stressed, it is more
appropriate to define the stress as perinatal rather than simply prenatal, and to consider
postnatal maternal factors as well.
Animal models of maternal stress across a diverse range of species, mainly mice [61],
rats [62], and guinea pigs [63], have demonstrated that prenatal stress increases offspring
GC stress sensitivity. A recent phylogenetic meta-analysis across 14 different vertebrate
species reported positive correlation between prenatal stress and dysregulated GC sen-
sitivity, in particular in the GC feedback mechanism [64], underlying the evolutionary
conserved mechanisms involved and therefore the usefulness of animal models for study-
ing prenatal programming of the HPA axis in humans.
Whenever both sexes were analyzed in the same study, sex differences emerged. For
example, in the early prenatal stress model developed by Bale’s group, in which pregnant
female mice are exposed to chronic stress during the first week of gestation, male offspring
were found to have a heightened GC response to stress while females were not affected.
By transcriptomic analysis of placenta at various gestational stages, the gene encoding the
enzyme O-linked N-acetylglucosamine transferase (OGT) was identified as a biomarker
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of prenatal stress as its mRNA expression was decreased by prenatal stress and it was
differentially regulated in male and female offspring [65]. In fact, OGT is a X-linked gene
escaping X-inactivation so down-regulation by prenatal stress has more incidences in males
since females hold two copies of the gene. By deleting OGT specifically in placenta, the
causal role of OGT in male offspring’s increased stress sensitivity was demonstrated [66].
Recently, the same group showed that one mechanism whereby OGT confer stress resilience
in females is by up-regulating the repressive epigenetic mark H3K27me3 in placenta as
demonstrated by the down-regulation of H3K27me3 in females through genetic manipula-
tion which render them vulnerable to prenatal stress with increased GC response to stress
as found in males [67].
In a nice translational study [68], blood mRNA expression of the gene GC-induced
leucine zipper (GILTZ encoded by Tsc22d3 gene) was found decreased in subjects with
post-traumatic stress disorder (PTSD), and especially in those that presented traumatic
events in childhood, both in males and females. However, only in males GILTZ mRNA
were significantly negatively correlated with the lifetime total number of traumatic events
experienced. Also, in males only, GILTZ mRNA were significantly negatively correlated
with the percentage of methylation of an intronic CpG island within the GILTZ gene
DNA sequence, suggesting regulation by methylation. To better understand these effects,
mouse models were used to further understand the mechanism by which multiple lifetime
traumas affect GILZ expression and its epigenetic regulation or by which one early-life
trauma predisposes to additional trauma later in life. The “one early-life trauma” consisted
of a prenatal stress induced by brain overexpression of CRF during late gestation and the
model of multiple trauma was the same prenatal stress plus a protocol of “stress enhanced
fear learning” at adulthood which induces PTSD-like symptoms in a subset of mice. As in
humans, prenatal stress predisposed male but not female mice to PTSD symptoms with
reduced GILTZ mRNA levels in amygdala correlated with increased methylation in a GRE
of the GILTZ gene DNA sequence. GILTZ gene being X-linked, females are less vulnerable
to changes in GILZ levels after trauma.
Another example of prenatal stress in human is given by the study of pregnancy
complicated with asthma [69] which results in increased levels of maternal cortisol. Pla-
cental 11β-HSD2 activity was found reduced in male and female placentae leading to
increase exposure to cortisol in both sexes but females only showed reduced birth weight,
which is believed to be a consequence of elevated cortisol exposure. It appears that male
placenta from pregnancy complicated by asthma display a state of GC resistance owing
to the expression of GRβ and to a low transactivational isoform GRαD1 [70]. CRF gene
expression was also up-regulated in female but not in male placenta. The authors proposed
that female adapt to the presence of maternal asthma through suppression of their immune
pathways via increased cortisol exposure at the expense of fetal growth but increased
survival, whereas male favor growth via a reduced sensitivity to cortisol although it leads
to increased risks of preterm birth or stillbirth.
5.2. Adolescent Period
Sex-specific long-term influences of adolescent stress exposure on adult responsive-
ness are highly dependent on the type of stressor experienced, the stage of adolescent
development during which the experience occurred, and species [34]. In rats, chronic
stress during adolescence was found to affect females with sustained behavioral effects
lasting until adulthood and impaired corticosterone response to acute stress while males
showed no changes either in adolescence or at adulthood [71]. Further investigations of
the same group revealed sex differences in baseline expression of GR co-chaperones and
modulators that were exacerbated by the combination of chronic stress and acute stress
challenge. More precisely, females presented lower peptidyl-prolyl isomerase D (Ppid)
mRNA in hippocampus at baseline but Ppid- and BCL-2-associated athanogene (Bag-1) is
induced and GR translocation to the nucleus increased by chronic stress in females only.
In response to an acute stressor GR, BAG-1, and FK506 binding protein 51 (FKBP5) are
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up-regulated 30 min after in females whereas males show changes in GR, FKBP5, and
nuclear receptor coactivator 1 (SRC-1) observed only 120 min after the challenge. These
data suggest enhanced GR sensitivity in chronically stressed adolescent females soon
after acute stress that appeared at later time points in males. Interestingly, Ppid mRNA
levels correlated with the increase in estradiol concentrations in chronically stressed but
not control females, underlying the interaction between sex steroid and chronic stress
in shaping GC signaling [72]. Independent studies confirmed increased vulnerability of
females for chronic stress during adolescence leading to blunted or increased HPA axis
reactivity depending on the type and intensity of the chronic stress [73–77].
Human studies are lacking to assess sex-specific programming effect of stress during
adolescence, although stressors specific to this period of life are important [78]. An impor-
tant difference with rats is that human hippocampus is fully developed by 2 years of age
whereas rat hippocampus continues to develop until adulthood rendering this region more
vulnerable to stress in adolescent rat. In both species, the frontal cortex develops well into
adolescence and amygdala even further until late twenties in humans. Thus, prefrontal
cortex is thought to be particularly sensitive to adversity in adolescents [22]. The effects of
acute stress exposure on prefrontal cortex and its connectivity with amygdala and ventral
striatum, regions also under active development during adolescence, are reviewed in [78].
The data provide support that the adolescence is vulnerable to changes in connectivity
between brain regions important for stress reactivity with some sex-specific effects.
The main findings explaining glucocorticoid stress differences in adults are summa-
rized in Figure 2.
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6. Discus ion
Sex differences in GC stress responses have b en largely studie because dysregulation
of GCs (hypo or hyperactivity) is a hallmark of many stress-related diseases, including psy-
chiatric disorders, inflammatory and autoimm ne diseases, or metabolic troub es [79,80].
While we have accumul ted an impress ve body of knowledge in the last 50 years about
stress and GC biology, we have barely scratched the surface concerning sex differences. Un-
til recently, most preclinical studies were done in males only and cli ical stud es were not
oft n designed to properly compare male and fe l subjects. Thi is progressively chang-
ing now that i clusion of both sexes in research projects is p omoted, if not compulsory, by
the funding agenci s of many countries [81].
In this review that does not intend to be exhaustive, I have summarized key ideas
and findings underpinning sexual dimorphism in GC stress responses at different stages
of development. Of note, the body adaptations to the environment are cumulative across
the life span, and its functioning at any later point in life is the result of experiences
and epigenetic alterations that take place during gestation, and throughout postnatal
development. Not reviewed here are recent studies highlighting the influence of stress
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before conception, for example extracellular vesicles that transmit information about stress
experience to sperm which could lead to sex-specific programming effects in offspring [82].
Although significant advances have been made, there are still a number of open
questions remaining. One of them concerned the consequences of differential GC responses
in terms of free GCs. Indeed, as pointed out in this review only free GCs are active
on the body but this is rarely measured in rodents and in humans it depends whether
cortisol is measured in saliva, where only free GCs are present contrary to plasma. The
dynamics of free GC were specifically measured in rats with microdialysis probes by
comparing free GCs in hippocampus after either a moderate stress (novel environment)
or after a high-intensity stress (forced swim). As expected the forced swim stress led
to higher free corticosterone levels in hippocampus compared to the moderate stress
but no sex differences were observed either in the peak response or in the AUC of the
free corticosterone response to both novelty and forced swim. The only change was a
slightly more rapid corticosterone elevation in females for the forced swim [83]. Using
isotopic dilution we also measured free GCs after forced swim in male and female mice
and confirmed no sex differences in free GC levels [23]. These data underlie the importance
of measuring free in addition to total GCs before interpreting sex differences.
Gender effects are also often overlooked in human research although they contribute
largely to the sexual dimorphism in GC stress response. Gender roles are socially con-
structed characteristics of men and women contrary to pure sex differences that are only
biological. In animal, gender roles do not exist but in human sex and gender effects are
combined as soon as an individual is socialized. Gender effects in stress response have
been first revealed in a study comparing men and women cortisol response after different
types of social stress. In the first one, the subjects are submitted to a fictitious job inter-
view with an unpleasant jury. Males showed on average a higher cortisol response than
females to this test while in another test based on social rejection from a group, opposite
responses were observed, with females displaying higher cortisol stress response. The
authors concluded that gender role may explain these results as males are generally more
affected by stress related to achievement while females would be more sensitive to stress
related to social rejection [84]. Some authors are going further, evoking the critical role
of gender socialization during childhood in shaping brain development and GC stress
response by encouraging boys to be more active, self-centered, and autonomous while girls
are more educated to provide care to others and are less valorized for autonomy. These
social interactions would be translated by epigenetic mechanisms in differential hormonal
and neuronal functioning in the developing brain [85]. While further studies are needed to
confirm this hypothesis, human stress studies would highly benefit from competences of
sociologists to evaluate the role of gender in explaining observed sex differences as pointed
out in an editorial of Nature journal [86] Life stresses!.
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